Antimicrobial therapy of experimental intraabdominal sepsis. 1975

W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach

Septic complications of colonic perforation involve miltiple bacteria derived from the intestinal flora. This type of mixed intraabdominal infection was produced experimentally by insertion of a standardized inoculum of rat colonic contents into the peritoneal cavity of male Wistar rats. The respective roles of coliforms and anerobic bacteria were then studied by use of selective antimicrobial therapy (with gentamicin and clindamycin). Untreated rats had a two-stage disease. Initally, there was an acute peritonitis associated with a 37% mortality rate; all animals that survived developed indolent intraabdominal abscesses. Treatment with gentamicin reduced the acute mortality rate to 4%, but 98% of the survivors had abscesses. Clindamycin acute mortalherapy was associated with a 35% mortality rate, but the incidence of intraabdominal abscess was only 5%. A combination of gentamicin and clindamycin yielded the salutary effects of each agent--7% mortality and 6% incidence of abscesses. These studies, in concert with bacteriological findings, suggest that coliforms caused early mortality while anaerobes were primarily responsible for the late complication of intraabdominal abscess formation.

UI MeSH Term Description Entries
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D000038 Abscess Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection. Abscesses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
January 1981, Reviews of infectious diseases,
W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
October 1994, The New Zealand medical journal,
W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
March 1981, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
December 1996, American journal of surgery,
W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
September 1978, The Journal of antimicrobial chemotherapy,
W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
March 1977, The Journal of infectious diseases,
W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
January 1984, Pediatric infectious disease,
W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
October 2015, The New England journal of medicine,
W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
October 2015, The New England journal of medicine,
W M Weinstein, and A B Onderdonk, and J G Bartlett, and T J Louie, and S L Gorbach
October 2015, The New England journal of medicine,
Copied contents to your clipboard!